首页> 外国专利> WOUND TREATMENT GEL OBTAINABLE BY COMBINING PLATELET RICH PLASMA WITH AUTOLOGOUSLY DERIVED THROMBIN

WOUND TREATMENT GEL OBTAINABLE BY COMBINING PLATELET RICH PLASMA WITH AUTOLOGOUSLY DERIVED THROMBIN

机译:伤口处理凝胶可以通过将血小板富血浆与自体衍生的凝血酶组合来获得

摘要

The present invention provides a method of making a wound treatment composition, wherein the method comprises; i) fractionating a whole blood sample into multiple samples including a platelet rich plasma (PRP) sample, a platelet poor plasma (PPP) sample and a erythrocyte sample, wherein the PRP sample has a haematocrit level of 1-10%, ii) processing a portion of the PPP and/or PRP sample to facilitate cleavage of autologous pro-thrombin present in the PPP and/or PRP to produce autologous thrombin, and iii) combining the PRP sample with a portion of the PPP sample and a portion of the thrombin produced in step (ii) to produce the wound treatment composition; wherein step ii) is performed at less than 15° C. In preferred embodiments the PRP has a haematocrit level of 2 or 8%. Wound treatment compositions produced by the methods are also provided as are compositions for use in treating chronic and acute wounds.
机译:本发明提供一种制备伤口处理组合物的方法,其中该方法包括; i)将全血样品分成多个样品,包括血小板富血浆(PRP)样品,血小板差的血浆(PPP)样品和红细胞样品,其中PRP样品具有1-10%,II)加工的血细胞比容水平PPP和/或PRP样品的一部分,以促进PPP和/或PRP中存在的自体促凝血酶的切割,以产生与PPP样品的一部分和一部分的PPP样品组合PRP样品的自体凝血酶和III)。步骤(ii)中产生的凝血酶产生伤口处理组合物;其中步骤II)在小于15℃下进行。在优选的实施方案中,PRP的血细胞比容水平为2或8%。还提供了通过该方法产生的伤口处理组合物是用于治疗慢性和急性伤口的组合物。

著录项

  • 公开/公告号EP3749336B1

    专利类型

  • 公开/公告日2021-05-19

    原文格式PDF

  • 申请/专利权人

    申请/专利号EP20190821179

  • 发明设计人 HADFIELD JANET;

    申请日2019-12-06

  • 分类号A61K35/16;A61K35/19;A61L24/10;A61L26;A61P17/02;

  • 国家 EP

  • 入库时间 2022-08-24 18:44:34

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号